Phototherapy Equipment Market Set To Grow To Over $810m By 2027

13 August 2018
Pharma

Visiongain has launched a new pharma report Global Phototherapy Equipment Market 2017-2027:Forecasts by Equipment Type (Conventional, LED-Based, Fibre-Optic), Application (Skin Disease, Neonatal Jaundice), End-User (Hospitals & Clinics, Home Use) and Geography

Phototherapy (light treatment) is the process of using light to eliminate bilirubin in the blood. These light waves are absorbed by the patient's skin and blood and change bilirubin into products which can pass through their system. Phototherapy treatment in the hospital has been traditionally been provided by a row of lights or a spotlight suspended at a distance from a baby. This would provide light shining directly on an undressed baby (with diaper on) whose eyes would need protection from the light with soft eye patches applied.

Today, advancements in technology have led to a new phototherapy system which gives effective treatment without the inconveniences of conventional phototherapy treatment. Treating psoriasis with a UVB light unit at home is an economical and convenient choice for many people. Like phototherapy in a clinic, it requires a consistent treatment schedule. Individuals are treated initially at a medical facility and then begin using a light unit at home.

The lead Visiongain report analyst for this report commented “Phototherapy is one of the most effective therapies which is carried out with the help of a special kind of light. Narrowband ultraviolet B (UVB) is the most common type of phototherapy used to treat eczema. Broadband UVB, PUVA (Psoralen and UVA) and UVA1 are other forms of phototherapy used in treating eczema.

The growth of the phototherapy market is majorly driven by rise in incidence of diseases such as neonatal jaundice, atopic dermatitis, psoriasis, vitiligo, acne vulgaris, cancer, wound healing and other skin diseases. The majority of these diseases are seen in new born children. However, the high cost of investment for research and development and high cost for relatively new classes of treatment for psoriasis and psoriatic arthritis makes the entry of new players difficult.”

The phototherapy equipment market is highly competitive with many different players entering the market. However, GE Healthcare, Philips Lighting Holding B.V. and Natus Medical Incorporated are the top competitors in the world phototherapy equipment market.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

Read

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

Read

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

Read

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever